SCHEMBL7807396

SCHEMBL7807396

O=c1nc(C(F)(F)F)cc2ccccc2n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 2/20 0.47
▸ HPGD P15428 3/20 0.45
▸ MAPT P10636 3/20 0.45
▸ ALDH1A1 P00352 3/20 0.45
▸ GLA P06280 1/20 0.45
▸ ACHE P22303 1/20 0.45
▸ ADORA2A P29274 1/20 0.40
▸ ADORA1 P30542 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ PDE2A O00408 1/20 0.39
▸ PDE3B Q13370 1/20 0.39
▸ PDE3A Q14432 1/20 0.39
▸ POLB P06746 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ PABPC1 P11940 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ IGF1R P08069 1/20 0.38
▸ KDM4E B2RXH2 4/20 0.38
▸ CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7802446 0.78 HPGD (0.45) CNR2HPGDMAPTALDH1A1GLA
SCHEMBL5503119 0.75 KDM4E (0.46) CNR2HPGDMAPTALDH1A1GLA
SCHEMBL29723103 0.70 CNR2 (0.49) CNR2HPGDMAPTALDH1A1GLA
SCHEMBL873852 0.70 CNR2 (0.49) CNR2HPGDMAPTALDH1A1GLA
SCHEMBL15346405 0.69 MAPT (0.48) CNR2HPGDMAPTALDH1A1GLA
Hydrochloric Acid SCHEMBL16825201 0.68 CNR2 (0.47) CNR2HPGDMAPTALDH1A1GLA
Hydrochloric Acid SCHEMBL4591179 0.68 CNR2 (0.47) CNR2HPGDMAPTALDH1A1GLA
SCHEMBL28215693 0.68 HPGD (0.58) CNR2HPGDMAPTALDH1A1GLA
Acridine SCHEMBL29526257 0.67 ALDH1A1 (0.94) HPGDMAPTALDH1A1GLAACHE
SCHEMBL2425904 0.67 ADORA2A (0.54) HPGDMAPTADORA2AADORA1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1091944-A1 1,3-BENZODIAZEPIN-2-ONES AND 1,3-BENZOXAZEPIN-2-ONES USEFUL AS HIV REVERSE TRANSCRIPTASE INHIBITORS Du Pont Pharmaceuticals Company (US) 2001-04-18 — — EP claimed
WO-2000000479-A1 1,3-BENZODIAZEPIN-2-ONES AND 1,3-BENZOXAZEPIN-2-ONES USEFUL AS HIV REVERSE TRANSCRIPTASE INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 2000-01-06 — — WO claimed
EP-1091944-A1 1,3-BENZODIAZEPIN-2-ONES AND 1,3-BENZOXAZEPIN-2-ONES USEFUL AS HIV REVERSE TRANSCRIPTASE INHIBITORS Du Pont Pharmaceuticals Company (US) 2001-04-18 — — EP disclosed
WO-2000000479-A1 1,3-BENZODIAZEPIN-2-ONES AND 1,3-BENZOXAZEPIN-2-ONES USEFUL AS HIV REVERSE TRANSCRIPTASE INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 2000-01-06 — — WO disclosed
Send feedback